% | $
Quotes you view appear here for quick access.

NPS Pharmaceuticals, Inc. Message Board

  • dcaf7 dcaf7 Sep 25, 2013 10:01 AM Flag

    Off-label Gattex reimbursement

    Janney ups target on NPS Pharma, sees off-label Gattex reimbursement • 9:53 AM
    •Janney sees evidence of off-label reimbursement for the NPS Pharmaceuticals' (NPSP +2%) SBS treatment Gattex. That's good news considering there are questions regarding insurer coverage push back.
    •Analyst Jim Molloy speculates Cigna and Blue Cross are already reimbursing off-label use. Janney's new price target for NPSP is $45.

45.970.00(0.00%)Feb 20 3:59 PMEST